英文名稱 |
中文名稱 |
CAS號(hào) |
操作 |
BMS-309403 |
BMS309403 |
300657-03-8 |
詳細(xì)
|
N-(3-(7-(1,3-dimethyl-1H-pyrazol-5-ylamino)-1-methyl-2-oxo-1,2-dihydropyrimido[4,5-d]pyrimidin-3(4H)-yl)-4-methylphenyl)-3-(trifluoromethyl)benzamide |
PLURIPOTIN |
839707-37-8 |
詳細(xì)
|
BI 882370 |
BI 882370 |
1392429-79-6 |
詳細(xì)
|
BI-7273 |
CS-2327 |
1883429-21-7 |
詳細(xì)
|
ICG-001 |
ICG-001 |
847591-62-2 |
詳細(xì)
|
FIIN-2 |
FIIN-2 |
1633044-56-0 |
詳細(xì)
|
Mardepodect (PF-2545920) |
2-[[4-[1-(甲基-11C)-4-(4-吡啶基)-1H-吡唑-3-基]苯氧基]甲基]喹啉 |
1292799-56-4 |
詳細(xì)
|
NLRP3-IN-10 |
化合物 NLRP3-IN-10 |
2641826-39-1 |
詳細(xì)
|
GF109203X.HCl |
3-[1-[3-(二甲基氨基)丙基]-1H-吲哚-3-基]-4-(1H-吲哚-3-基)-1H-吡咯-2,5-二酮單鹽酸鹽 |
176504-36-2 |
詳細(xì)
|
ALW-II-49-7 |
化合物 ALW-II-49-7 |
1135219-23-6 |
詳細(xì)
|
Nampt activator-1 |
化合物 NAMPT ACTIVATOR-1 |
701929-65-9 |
詳細(xì)
|
DC-TEADin02 |
化合物DC-TEADIN02 |
2380228-45-3 |
詳細(xì)
|
Quipazine dimaleate |
美托拉宗 |
150323-78-7 |
詳細(xì)
|
6-quinolinyl(3,4,5-trimethoxyphenyl)methanone |
B014 |
1215208-59-5 |
詳細(xì)
|
BRD4 Inhibitor-20 |
化合物 BRD4 INHIBITOR-20 |
2490311-14-1 |
詳細(xì)
|
4-[(Benzo[b]thien-3-ylcarbonyl)[2-(4-chlorophenyl)ethyl]amino]-N-(2,4-difluorophenyl)-1-piperidinecarboxamide |
4-[(苯并[B]噻吩-3-基羰基)[2-(4-氯苯基)乙基]氨基]-N-(2,4-二氟苯基)-1-哌啶甲酰胺 |
1092847-21-6 |
詳細(xì)
|
5-(6-Hydroxybenzofuran-2-yl)-2-(3-methyl-2-butenyl)-1,3-benzenediol |
5-(6-羥基-2-苯并呋喃基)-2-(3-甲基-2-丁烯基)-1,3-苯二醇 |
69120-06-5 |
詳細(xì)
|
WAY-658513 |
2-(2-氯-6-氟苯基)-N-(4-(吡啶-4-基)噻唑-2-基)乙酰胺 |
692870-25-0 |
詳細(xì)
|
CH-223191 |
1-甲基-N-[2-METHYL-4-[2-(2-甲苯基)二氮烯基]苯基-1H-吡唑-5-甲酰胺 |
301326-22-7 |
詳細(xì)
|
PFI-90 |
N'-(吡啶-2-基)吡啶-2-甲酰肼 |
53995-62-3 |
詳細(xì)
|
IDF11774 |
無(wú)中文名稱 |
1429054-28-3 |
詳細(xì)
|
FG 2216 |
BIQ |
223387-75-5 |
詳細(xì)
|
1-(4-Methoxyphenyl)-2-methyl-3-nitro-1H-indol-6-ol |
1-(4-甲氧基苯基)-2-甲基-3-硝基-1H-吲哚-6-醇 |
147591-46-6 |
詳細(xì)
|
RO3280 |
RO3280 |
1062243-51-9 |
詳細(xì)
|
2-(2-Chlorophenyl)-4-(3-(diMethylaMino)phenyl)-5-Methyl-1H-pyrazolo[4,3-c]pyridine-3,6(2H,5H)-dione |
2-(2-氯苯基)-4-[3-(二甲基氨基)苯基]-5-甲基-1H-吡唑并[4,3-C]吡啶-3,6(2H,5H)-二酮 |
1218942-37-0 |
詳細(xì)
|
G007-LK |
G007-LK |
1380672-07-0 |
詳細(xì)
|
N-(2-[P-BROMOCINNAMYLAMINO]ETHYL)-5-ISOQUINOLINESULFONAMIDE HYDROCHLORIDE |
N-[2-[P-溴苯丙烯鹽基氨基]乙基]-5-異喹啉磺酰胺 |
127243-85-0 |
詳細(xì)
|
KN92 phosphate |
KN-92 磷酸鹽 |
1135280-28-2 |
詳細(xì)
|
BMS-687453 |
BMS 687453 |
1000998-59-3 |
詳細(xì)
|
TYRPHOSTIN AG 528 |
酪氨酸磷酸化抑制劑AG528 |
133550-49-9 |
詳細(xì)
|
SD-06 |
3-[N-(2-羥基乙酰基)-4-哌啶基]-4-(4-嘧啶基)-5-(4-氯苯基)吡唑 |
271576-80-8 |
詳細(xì)
|
AM-0902 |
AM0902 |
1883711-97-4 |
詳細(xì)
|
CS-2716 |
CS-2716 |
901751-47-1 |
詳細(xì)
|
TRPM8 Antagonist |
TRPM8 拮抗劑 |
259674-19-6 |
詳細(xì)
|
N-(4-Chloro-2-isopropoxybenzyl)-5-phenyl-[1,2,4]triazolo[1,5-a]pyrimidin-7-amine |
CS-2866 |
1637300-25-4 |
詳細(xì)
|
DMU2105 |
CS-2868 |
1031063-36-1 |
詳細(xì)
|
PD173955 |
6-(2,6-二氯苯基)-8-甲基-2-[[3-(甲硫基)苯基]氨基]吡啶并[2,3-D]嘧啶-7(8H)-酮 |
260415-63-2 |
詳細(xì)
|
Seclidemstat |
SECLIDEMSTAT |
1423715-37-0 |
詳細(xì)
|
PD0166285 |
6-(2,6-二氯苯基)-2-[[4-[2-(二乙基氨基)乙氧基]苯基]氨基]-8-甲基吡啶并[2,3-D]嘧啶-7(8H)-酮 |
185039-89-8 |
詳細(xì)
|
5-PyriMidinecarboxaMide, 2-[[2-(3-chloro-4-hydroxyphenyl)ethyl]aMino]-4-[(phenylMethyl)aMino]- |
AS1517499 |
919486-40-1 |
詳細(xì)
|
CK 869 |
CK-869 |
388592-44-7 |
詳細(xì)
|
3-Phenyl-5-(3,4,5-trimethoxyphenyl)-4,5-dihydro-1H-pyrazole-1-carbothioamide |
1370046-40-4 |
1370046-40-4 |
詳細(xì)
|
2-(2-chlorophenyl)-4-Methyl-5-(pyridin-2-ylMethyl)-1H-pyrazolo[4,3-c]pyridine-3,6(2H,5H)-dione |
AK120765 |
955272-06-7 |
詳細(xì)
|
XMD8-92 |
2-[[2-乙氧基-4-(4-羥基-1-哌啶基)苯基]氨基]-5,11-二氫-5,11-二甲基-6H-嘧啶并[4,5-B][1,4]苯并二氮雜卓-6-酮 |
1234480-50-2 |
詳細(xì)
|
SCRIPTAID |
SCRIPTAID |
287383-59-9 |
詳細(xì)
|
LYN-1604 |
藍(lán)木定制的新產(chǎn)品 |
2088939-99-3 |
詳細(xì)
|
6-(2,4-Dichlorophenyl)-8-ethyl-2-((3-fluoro-4-(piperazin-1-yl)phenyl)amino)pyrido[2,3-d]pyrimidin-7(8H)-one |
FRAX486 |
1232030-35-1 |
詳細(xì)
|
4-(4-(2,3-DIHYDROBENZO[1,4]DIOXIN-6-YL)-5-PYRIDIN-2-YL-1H-IMIDAZOL-2-YL)BENZAMIDE |
4-[4-(2,3-二氫-1,4-苯并二氧雜環(huán)己-6-基)-5-(2-吡啶基)-1H-咪唑-2-基]苯甲酰胺 |
301836-43-1 |
詳細(xì)
|
MHY1485 |
MHY1485 |
326914-06-1 |
詳細(xì)
|
LIT-927 |
LIT-927游離 |
2172879-52-4 |
詳細(xì)
|
2-Phenylacrylic Acid |
2-苯基丙烯酸 |
492-38-6 |
詳細(xì)
|
Afimoxifene |
阿非昔芬 |
68392-35-8 |
詳細(xì)
|
2070015-25-5 |
EPZ020411 HCL |
2070015-25-5 |
詳細(xì)
|
6-fluoro-5-[4-[(5-fluoro-2-methyl-3-oxo-4H-quinoxalin-6-yl)methyl]-1-piperazinyl]-N-methyl-2-pyridinecarboxamide |
AZD-9574 |
2756333-39-6 |
詳細(xì)
|
(3S)-3-[4-[4-[(4S)-1-[[2,6-dimethoxy-4-(1,4,5-trimethyl-6-oxo-3-pyridinyl)phenyl]methyl]-3,3-difluoro-4-piperidinyl]-1-piperazinyl]-3-fluoroanilino]piperidine-2,6-dione |
CFT8634 |
2704617-96-7 |
詳細(xì)
|
S63845 |
S63845 |
1799633-27-4 |
詳細(xì)
|
136609-26-2 |
RP70676 |
136609-26-2 |
詳細(xì)
|
TC-DAPK 6 |
TC-DAPK 6 |
315694-89-4 |
詳細(xì)
|
(5Z)-2-hydroxy-4-methyl-6-oxo-5-[(5-phenylfuran-2-yl)methylidene]-5,6-dihydropyridine-3-carbonitrile |
ZINC05007751 |
591239-68-8 |
詳細(xì)
|
Nω-Hydroxy-nor-L-Arginine Dihydrochloride |
N蠅-Hydroxy-nor-L-Arginine Dihydrochloride |
291758-32-2 |
詳細(xì)
|
APY0201 |
化合物APY0201 |
1232221-74-7 |
詳細(xì)
|
Liproxstatin-1 |
利普司他丁-1 |
950455-15-9 |
詳細(xì)
|
Unii-VQ7NU11krm |
Benzamide, 4-[(di-2-pyrazinylamino)methyl]-N-hydroxy- |
1636894-46-6 |
詳細(xì)
|
PFK-158 |
PFKFB3抑制劑(PFK-158) |
1462249-75-7 |
詳細(xì)
|
SLV-319 |
362519-49-1 |
362519-49-1 |
詳細(xì)
|
(+/-)-BAY K 8644 |
1,4-二氫-2,6-二甲基-5-硝基-4-(2-[三氟甲基]苯基)吡啶-3-羧酸甲酯 |
71145-03-4 |
詳細(xì)
|
SJA710 6; SJA710-6; SJA-710-6; SJA 710-6 |
SJA710-6 |
1397255-09-2 |
詳細(xì)
|
AC-5216 |
AC-5216 |
226954-04-7 |
詳細(xì)
|
m-tolyl 5-chloro-2-(ethylsulfonyl)pyrimidine-4-carboxylate |
SBI-115 |
882366-16-7 |
詳細(xì)
|
3-[(5-CHLORO-2-HYDROXYPHENYL)METHYL]-5-[4-(TRIFLUOROMETHYL)PHENYL]-1,3,4-OXADIAZOL-2(3H)-ONE |
3-(5-CHLORO-2-HYDROXYBENZYL)-5-(4-(TRIFLUOROMETHYL)PHENYL)-1,3,4-OXADIAZOL-2(3H)-ONE |
202821-81-6 |
詳細(xì)
|
N-(6-Fluoro-1H-indazol-5-yl)-2-methyl-6-oxo-4-[4-(trifluoromethyl)phenyl]-1,4,5,6-tetrahydro-3-pyridinecarboxamide |
N-(6-氟-1H-吲唑-5-基)-2-甲基-6-氧代-4-[4-(三氟甲基)苯基]-1,4,5,6-四氫-3-吡啶甲酰胺 |
864082-47-3 |
詳細(xì)
|
RHPS4 |
RHPS4 |
390362-78-4 |
詳細(xì)
|
ERK5-IN-2 |
ERK5-IN-2 |
1888305-96-1 |
詳細(xì)
|
Ellipticine (hydrochloride) |
玫瑰樹(shù)堿鹽酸鹽 |
5081-48-1 |
詳細(xì)
|
GLX351322 |
CS-2871 |
835598-94-2 |
詳細(xì)
|
SGI-1027 |
SGI-1027 |
1020149-73-8 |
詳細(xì)
|
N2-(2-((4-(2,4-Dichlorophenyl)-5-(1H-imidazol-1-yl)pyrimidin-2-yl)amino)ethyl)-5-nitropyridine-2,6-diamine |
CHIR98014(CT98014) |
252935-94-7 |
詳細(xì)
|
TRPM4-IN-2 |
化合物 TRPM4-IN-2 |
667411-04-3 |
詳細(xì)
|
W-5074 |
GW5074 |
220904-83-6 |
詳細(xì)
|
SB-366791 |
3-(4-氯苯基)-N-(3-甲氧基苯基)-2-丙烯酰胺 |
472981-92-3 |
詳細(xì)
|
SU-5607 IC 261 |
3-(2,4,6-三甲氧基苯亞甲基)吲哚啉-2-酮 |
186611-52-9 |
詳細(xì)
|
Dynasore |
DYNASORE |
304448-55-3 |
詳細(xì)
|
Hydroxy-Dynasore |
DYNGO-4A |
1256493-34-1 |
詳細(xì)
|
A K2 |
2-氰基-3-[5-(2,5-二氯苯基)-2-呋喃基]-N-5-喹啉基-2-丙烯酰胺 |
304896-28-4 |
詳細(xì)
|
WH-4-023 |
2,6-DIMETHYLPHENYL 2,4-DIMETHOXYPHENYL(2-(4-(4-METHYLPIPERAZIN-1-YL)PHENYLAMINO)PYRIMIDIN-4-YL)CARBAMATE |
837422-57-8 |
詳細(xì)
|
(E/Z) O289 |
GO 289) |
694522-87-7 |
詳細(xì)
|
PF-00299804 |
:達(dá)克替尼一水合物 |
1042385-75-0 |
詳細(xì)
|
Regorafenib (Hydrochloride) |
瑞格非尼鹽酸鹽 |
835621-07-3 |
詳細(xì)
|
4-[4-[[[[4-Chloro-3-(trifluoromethyl)phenyl]amino]carbonyl]amino]-3-fluorophenoxy]-N-methyl-2-pyridinecarboxamide hydrate |
瑞格非尼一水合物 |
1019206-88-2 |
詳細(xì)
|
2-Propenamide, N-[4-[(3-chloro-4-fluorophenyl)amino]-7-[3-(4-morpholinyl)propoxy]-6-quinazolinyl]-, hydrochloride (1:2) |
卡紐替尼二鹽酸鹽 |
289499-45-2 |
詳細(xì)
|
Aceclofenac |
醋氯芬酸 |
89796-99-6 |
詳細(xì)
|
ALLN |
鈣蛋白酶抑制劑I |
110044-82-1 |
詳細(xì)
|
MG-132 |
MG132,蛋白酶體抑制劑 |
133407-82-6 |
詳細(xì)
|
Ebselen |
依布硒 |
60940-34-3 |
詳細(xì)
|
GI 254023X |
(ALPHAR)-N-[(1S)-2,2-二甲基-1-[(甲基氨基)羰基]丙基]-ALPHA-[(1S)-1-(甲?;u基氨基)乙基]苯戊酰胺 |
260264-93-5 |
詳細(xì)
|
(S)-3-((S)-2-(2-(2-tert-butylphenylamino)-2-oxoacetamido)propanamido)-4-oxo-5-(2,3,5,6-tetrafluorophenoxy)pentanoic acid |
N-[2-(叔丁基)苯基]-2-氧代甘氨酰-N-[(1S)-1-(羧基甲基)-2-氧代-3-(2,3,5,6-四氟苯氧基)丙基]-L-丙氨酰胺 |
254750-02-2 |
詳細(xì)
|
RX-3117 |
RX-3117 |
865838-26-2 |
詳細(xì)
|
SID 487795 |
NSC617145 |
203115-63-3 |
詳細(xì)
|
MCC950 |
MCC950 |
210826-40-7 |
詳細(xì)
|
Alda-1 |
N-(1,3-苯并二氧雜環(huán)戊烯-5-基甲基)-2,6-二氯苯甲酰胺 |
349438-38-6 |
詳細(xì)
|